mym-v101
Vaccineexperimental
Clinical trial activity
1 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2009 (NCT01084343)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mym-v101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01084343 | Phase 1 | Nov 1, 2009 | Ghent University, Institut Cochin, Kinesis Pharma, Mouton's Safety Consultancy, Mymetics Corporation, Pevion Biotech Ltd, Sorbonne University, University of Milan |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ghent University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Institut Cochin | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Kinesis Pharma | For profit | 1 | 0 | 1 | 2009 |
| Mouton's Safety Consultancy | For profit | 1 | 0 | 1 | 2009 |
| Mymetics Corporation | For profit | 1 | 1 | 1 | 2009 |
| Pevion Biotech Ltd | For profit | 1 | 0 | 1 | 2009 |
| Sorbonne University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Milan | Academic/Hospital | 1 | 0 | 1 | 2009 |
8 organizations
Page 1 / 1